Nova EYE Medical Ltd Total Liabilities
Nova EYE Medical Ltd total liabilities. Based on the latest financial reports, Nova EYE Medical Ltd (EYE) has total liabilities worth AU$7.31 Million AUD (≈ $5.17 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are Nova EYE Medical Ltd's assets to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Nova EYE Medical Ltd (1989–2026)
Total liabilities of Nova EYE Medical Ltd from 1989 to 2026. This chart illustrates how Nova EYE Medical Ltd's total liabilities have evolved over time, based on quarterly financial data.
Nova EYE Medical Ltd Competitors by Total Liabilities
The table below lists competitors of Nova EYE Medical Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Nath Bio-Genes (India) Limited
NSE:NATHBIOGEN
|
India | Rs4.17 Billion |
|
Bangkok Sheet Metal Public Company Limited
BK:BM
|
Thailand | ฿938.51 Million |
|
Microbix Biosystems Inc.
TO:MBX
|
Canada | CA$9.80 Million |
|
Juic International
TWO:6114
|
Taiwan | NT$743.66 Million |
|
Tikun Olam Cannbit Pharmaceuticals Ltd
TA:TKUN
|
Israel | ILA27.50 Million |
|
Pico (Thailand) Public Company Limited
BK:PICO
|
Thailand | ฿259.55 Million |
|
Aquaron Acquisition Corp. Common Stock
NASDAQ:AQU
|
USA | $5.64 Million |
|
Xbrane Biopharma AB
ST:XBRANE
|
Sweden | Skr103.76 Million |
Liability Composition Analysis (1989–2026)
This chart breaks down Nova EYE Medical Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Nova EYE Medical Ltd balance sheet assets.
Liquidity & Leverage Metrics
Nova EYE Medical Ltd Total Liabilities Ratios Explained
Nova EYE Medical Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.74 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.51 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.34 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Nova EYE Medical Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Nova EYE Medical Ltd (1989–2026)
The table below shows the annual total liabilities of Nova EYE Medical Ltd from 1989 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-06-30 | AU$7.31 Million ≈ $5.17 Million |
-2.97% |
| 2025-06-30 | AU$7.54 Million ≈ $5.33 Million |
-11.87% |
| 2024-06-30 | AU$8.55 Million ≈ $6.05 Million |
+19.34% |
| 2023-06-30 | AU$7.17 Million ≈ $5.07 Million |
+15.06% |
| 2022-06-30 | AU$6.23 Million ≈ $4.41 Million |
-6.47% |
| 2021-06-30 | AU$6.66 Million ≈ $4.71 Million |
-58.78% |
| 2020-06-30 | AU$16.16 Million ≈ $11.43 Million |
-48.05% |
| 2019-06-30 | AU$31.10 Million ≈ $22.00 Million |
+2.90% |
| 2018-06-30 | AU$30.22 Million ≈ $21.38 Million |
+2.07% |
| 2017-06-30 | AU$29.61 Million ≈ $20.95 Million |
+24.76% |
| 2016-06-30 | AU$23.73 Million ≈ $16.79 Million |
+23.70% |
| 2015-06-30 | AU$19.19 Million ≈ $13.58 Million |
+11.04% |
| 2014-06-30 | AU$17.28 Million ≈ $12.23 Million |
+4.61% |
| 2013-06-30 | AU$16.52 Million ≈ $11.69 Million |
+28.30% |
| 2012-06-30 | AU$12.87 Million ≈ $9.11 Million |
-28.72% |
| 2011-06-30 | AU$18.06 Million ≈ $12.78 Million |
-1.80% |
| 2010-06-30 | AU$18.39 Million ≈ $13.01 Million |
-11.81% |
| 2009-06-30 | AU$20.85 Million ≈ $14.76 Million |
-13.11% |
| 2008-06-30 | AU$24.00 Million ≈ $16.98 Million |
+18.19% |
| 2007-06-30 | AU$20.31 Million ≈ $14.37 Million |
+79.20% |
| 2006-06-30 | AU$11.33 Million ≈ $8.02 Million |
+12.59% |
| 2005-06-30 | AU$10.06 Million ≈ $7.12 Million |
+28.45% |
| 2004-06-30 | AU$7.84 Million ≈ $5.54 Million |
+20.83% |
| 2003-06-30 | AU$6.49 Million ≈ $4.59 Million |
-18.56% |
| 2002-06-30 | AU$7.96 Million ≈ $5.63 Million |
+2138.06% |
| 2001-06-30 | AU$355.80K ≈ $251.75K |
+77.09% |
| 2000-06-30 | AU$200.91K ≈ $142.16K |
+318.16% |
| 1999-06-30 | AU$48.05K ≈ $34.00K |
+9.86% |
| 1998-06-30 | AU$43.73K ≈ $30.94K |
-51.97% |
| 1997-06-30 | AU$91.06K ≈ $64.43K |
+94.34% |
| 1996-06-30 | AU$46.86K ≈ $33.16K |
+112.99% |
| 1995-06-30 | AU$22.00K ≈ $15.57K |
-12.00% |
| 1994-06-30 | AU$25.00K ≈ $17.69K |
-57.63% |
| 1993-06-30 | AU$59.00K ≈ $41.75K |
-42.72% |
| 1992-06-30 | AU$103.00K ≈ $72.88K |
+0.98% |
| 1991-06-30 | AU$102.00K ≈ $72.17K |
-78.02% |
| 1990-06-30 | AU$464.00K ≈ $328.31K |
+122.01% |
| 1989-06-30 | AU$209.00K ≈ $147.88K |
-- |
About Nova EYE Medical Ltd
Nova Eye Medical Limited designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally. The company operates through Glaucoma Surgical Devices and AlphaRET segments. It offers 2RT, a proprietary laser technology to treat patients in early and intermediate age-related macular degener… Read more